Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

065. Virology: Treatment and Prevention of Viral Infections: Thursday, 12:15 - 1:30 p.m.

Poster Session: Virology: Treatment and Prevention of Viral Infections

(923) EDP-938, A Respiratory Syncytial Virus (RSV) antiviral, demonstrates a high barrier to resistance in a human challenge study

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • Rachel E. Levene, PhD

    Scientist
    Enanta Pharmaceuticals
    Watertown, Massachusetts, United States

    • Co-Author(s)

  • JD

    John DeVincenzo, MD

    Vice President, Translational Virology
    Enanta Pharmaceuticals
    Watertown, Massachusetts, United States

  • AC

    Annie Conery, Ph.D.

    Director, Clinical Research Scientist
    Enanta Pharmaceuticals
    Watertown, Massachusetts, United States

  • AA

    Alaa Ahmad, PhD

    Senior Director & Head, Clinical Pharmacology
    Enanta Pharmaceuticals
    Watertown, MA, United States

  • BG

    Bryan Goodwin, Ph.D.

    Vice President, Biology
    Enanta Pharmaceuticals
    Watertown, Massachusetts, United States

  • YO

    Yat Sun Or, Ph. D

    CSO
    Enanta Pharmaceuticals, Inc.
    Watertown, MA, United States

  • MR

    Michael Rhodin, Ph. D

    Scientist
    Enanta Pharmaceuticals, Inc.
    Watertown, MA, United States